
View larger version (80K):
[in a new window]
|
Fig. 10. RhoA mutations disrupt lumen formation, the organization of apical cytoskeletal structures and apical determinant localization in tracheal cells. (A-C) Stacks of eight 1 µm confocal sections; embryos stained with mAb 2A12 to reveal the lumen. (A) Stage 16 embryo that expresses RhoAV14 in all tracheal cells (RhoAV14 embryo). Fusion cells in the dorsal and lateral trunk do not form bridging lumenal connections. (B) Stage 15 embryo that expresses RhoAN19 in all tracheal cells (RhoAN19 embryo). 2A12 antigen does not accumulate in a discrete lumenal space, and is diffusely distributed extracellularly. (C) Stage 15 embryo that expresses Cdc42N17 in all tracheal cells (Cdc42N17 embryo). The lumen is continuous through fusion cells. (D-Q) Confocal sections (1 µm) through dorsal trunk cells. (D) Stage 14, RhoAV14. F-actin surrounds blind-ended lumens at anastomosis sites. (E) Stage 14, RhoAN19. F-actin accumulates in patches in all tracheal cells. The patches tend to be in the center of the dorsal trunk, but do not form a normal subapical structure. (F) Stage 14, Cdc42N17. The F-actin distribution appears normal. (G) Stage 14, RhoAV14. In fusion cells, Dlt accumulates apically around blind-ended lumens. (H) Stage 14, RhoAN19. Dlt is more broadly distributed than in wild-type tracheal cells. (I) Stage 14, Cdc42N17. Dlt accumulates apically in all tracheal cells, as in stage 14 wild-type embryos. (J) Stage 15, RhoAV14. E-Cadherin fails to form a three-ringed structure at anastomosis sites. (K) Stage 15, RhoAN19. E-cadherin distribution is similar to wild-type (Fig. 4J). (L) Stage 15, RhoAV14. In fusion cells, Shot L(A)-GFP accumulates apically, but the lumens are blind-ended. (M) Stage 15, RhoAN19. Shot L(A)-GFP is no longer apically concentrated. (N) Stage 15, RhoAV14. Microtubules fail to accumulate apically in tracheal cells. (O) Stage 15, RhoAN19. Microtubules fail to accumulate apically in tracheal cells. (P) Stage 13, RhoAV14. No E-cadherin contact (arrow) is detectable between fusion cells. (Q) Stage 13, RhoAV14. No F-actin track (arrow) is detectable in fusion cells. Scale bars: in C, 25 µm for A-C; in O, 10 µm for D-O.
|